Return to List

Study Summary
No. 2003-0460:.......Phase I Studies......Roy S. Herbst......Thoracic and Head and Neck Medical Oncology
.
Study Summary Title
Study Summary
Number:		2003-0460
Study Title:A Phase I, First in Human, Open-Label, Dose Finding Study Evaluating the Safety and Pharmacokinetics of AMG 706 in Subjects with Advanced Solid Tumors
.
Physician New Patient Referral
Name:Roy S. HerbstPatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Thoracic and Head and Neck Medical OncologyReferring MD
Call:		800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-792-6363
Contact us about clinical trials
.
General Information
Disease Group:Phase I StudiesSupported By:Amgen
Phase of Study:1Return
Visit:		Every 2 weeks after the first 8 weeks.
Treatment
Agents:		Imaging
Collection
Screening
amg 706		Home Care:None
Treatment Loc:outpatient
Estimated
Length of Stay
in Houston:		None
Description/
Intervention:		Unavailable
.
Study Objectives / Outcomes
Unavailable
.
Study Status Information
Study Activation / Registration Date:07/17/2003
IRB Review and Approval Date:06/18/2003
Study Type:Therapeutic
Recruitment Status:Closed
Projected Accrual:55
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.
Inclusion Criteria:Patient is equal to or greater than 18 years of age.

Before any study-specific procedure, the IRB approved informed consent must be obtained.
Return to Clinical Trials at M.D. Anderson Cancer Center